FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Dexamethasone Sodium Phosphate Injection

  • U.S. Food and Drug Administration
  • August 20, 2026
  • ID: shortage-dexamethasone-sodium-phosphate-injection-mylan-institutional-a-viatris-company-67457-422-54

Drug Shortage Details

Generic NameDexamethasone Sodium Phosphate Injection
Manufacturer / CompanyMylan Institutional, a Viatris Company
Therapeutic CategoryDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code67457-422-54
Presentation & Dosage Form

Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)

Manufacturer Contact Info

800-796-9526


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.